Literature DB >> 8597766

Measurement of prostate specific antigen as screening test for prostate cancer. Trials of treatment are needed before trials of screening.

S Sandhu, R Morris, V Matveev, A V Kaisary.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8597766      PMCID： PMC2350510          DOI： 10.1136/bmj.312.7032.709a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up.

Authors:  P H Graversen; K T Nielsen; T C Gasser; D K Corle; P O Madsen
Journal:  Urology       Date:  1990-12       Impact factor: 2.649

2.  Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association.

Authors:  R G Middleton; I M Thompson; M S Austenfeld; W H Cooner; R J Correa; R P Gibbons; H C Miller; J E Oesterling; M I Resnick; S R Smalley
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

Review 3.  Recent results of management of palpable clinically localized prostate cancer.

Authors:  J Adolfsson; G Steineck; W F Whitmore
Journal:  Cancer       Date:  1993-07-15       Impact factor: 6.860

4.  Psychological reactions in men screened for prostate cancer.

Authors:  O Gustafsson; T Theorell; U Norming; A Perski; M Ohström; C R Nyman
Journal:  Br J Urol       Date:  1995-05

5.  Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer.

Authors:  C Parkes; N J Wald; P Murphy; L George; H C Watt; R Kirby; P Knekt; K J Helzlsouer; J Tuomilehto
Journal:  BMJ       Date:  1995-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.